Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2019 2020 2021 2022 2023 2024 2025
Months
January February March April May June July August September October November December
Previous Archive
06 April 2022 | Story Lacea Loader
NSFAS

The National Student Financial Aid Scheme (NSFAS) confirmed in a circular this week that monies will be paid to universities on 8 April 2022.

This will be the first payment that the University of the Free State (UFS) receives from NSFAS this year, as per the media statement by the Minister of Higher Education, Science and Innovation, Dr Blade Nzimande.

So far this year, the UFS management has made several concessions to students to alleviate their financial pressure while waiting for their NSFAS subsidies to be released.

This week, the university management – through active engagements and input from the Institutional Student Representative Council (ISRC) – agreed on the following process for book and meal allowances to be transferred to students’ bank accounts at the earliest possible opportunity:

  1. As in the past, the services of Fundi will be used to pay the allowances to students.
  2. Fundi will inform the recipients of monies received for them.
  3. After the banking details of students have been validated, monies are transferred to a student’s bank account. Fundi will inform students whose banking details are incorrect to rectify it on the Fundi website.
  4. Students who have not received payments before, will be requested to upload their banking details on the Fundi website, after which payment will be made.

It is anticipated that students whose bank accounts are with Standard Bank will receive notice of the payment of their allowance as soon as Friday, 8 April 2022.

Students banking with other banks will receive their payments subject to the inter-banking money transfer policies of the different banks, but not later than two business days after payment.

What students must do:

  1. Ensure that you upload the correct banking details.
  2. Upload your OWN banking details, not the banking details of friends or family.
  3. Ensure that your cellphone number is correct and active on PeopleSoft.
  4. Respond as quickly as possible to SMSes received from Fundi.

The university management would like to thank the majority of students for their patience during this difficult time while waiting for the NSFAS subsidies to be released.


Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept